AMKR — Amkor Technology
Thesis
Stance: WATCH — high-quality thesis, poor entry. Conviction: Medium (thesis) / Low (entry timing). Amkor is the highest-quality, US-domiciled gateway into the advanced packaging supercycle, and the best US-domiciled vehicle for the AI infrastructure build-out. It holds the #2 global OSAT position behind only ASE Technology, commands irreplaceable relationships with Apple (~30% of revenue) and Qualcomm (~11%), and is now the first OSAT chosen by Intel to assemble EMIB — Intel's premier advanced packaging interconnect (announced Dec 2025). The near-term story is capex pain: a $7B Arizona campus commitment makes FCF deeply negative through 2027. The medium-term story is capacity scarcity: when Arizona comes online in 2028, Amkor will be the only large-scale, CHIPS-Act-funded, US-soil advanced packaging campus serving customers who need supply chain resilience. Near-term pain creates an entry window for a 2028-2030 payoff.
What has to be true. The single most important thing: Arizona Phase 1 must hit its production target (early 2028) and fill to meaningful utilization with Apple/NVIDIA volume within 12-18 months of opening. Secondary: AI compute advanced packaging demand continues; Intel EMIB volume materializes (contingent on Intel 18A winning external customers); gross margin recovers above 14% post-ramp. The Intel EMIB partnership is the most speculative incremental catalyst — revenue is near zero today and depends entirely on Intel 18A external wins. The Apple/NVIDIA Arizona anchors are the higher-confidence, more near-term drivers.
The tension. Is the stock already pricing the 2028 payoff? At ~$46-47/share (deep-dive research entry, April 2026) the entry was reasonable; by the time of the pre-buy checklist (April 26, 2026, one day before Q1 earnings) the stock had surged ~70% to ~$78 on AI packaging sentiment, a Melius Research upgrade, and pre-earnings positioning — running above all analyst price targets (consensus $52.88) and trading at ~52x TTM P/E. At $78 the thesis is intact but the entry is poor; this is a valuation problem, not a thesis problem. The pre-buy recommendation: do not buy before Q1 2026 earnings; wait for post-earnings price discovery; target entry $55-70 depending on outcome.
Bear case target: ~$24-28/share (~40-50% downside from $46; ~64-68% from $78) if Arizona is delayed 12+ months and Intel EMIB fails. Position sizing should reflect that a 40-50% drawdown is a plausible bear case, not a tail scenario. Max position 2-3% of portfolio; scale to 5% only after Arizona Phase 1 equipment-installation milestone.
Snapshot
Amkor Technology, Inc. — world's largest US-headquartered OSAT (outsourced semiconductor assembly and test) provider; #2 globally by revenue behind ASE Technology; primary packaging partner for Apple, Qualcomm, and newly the first OSAT chosen by Intel for EMIB.
- Ticker / Exchange: AMKR / Nasdaq Global Select Market
- Sector / GICS: Semiconductors & Semiconductor Equipment (OSAT; advanced packaging)
- HQ: Tempe, Arizona, USA | Founded: 1968 (as a packaging broker in Korea by James J. Kim) | IPO: May 2, 2000
- Website: amkor.com | Latest IR deck: July 2025 Investor Presentation
Price / valuation snapshot (April 2026 — research-date prices, approximate):
- Price: ~$46-47/share (deep-dive/profile research date) → ~$78/share (checklist date, April 24, 2026 close)
- Market cap: ~$19.4B at deep-dive (note: profile and checklist both also cite ~$19.4B at $78 — there is a share-count inconsistency across fragments; checklist shows ~$11.4B at $46 vs ~$19.4B at $78, which is internally consistent at ~248M shares, implying the deep-dive's "$19.4B at $46" is the stale figure)
- Enterprise value: ~$18.9B (deep-dive) to ~$19.9B (checklist at $78)
- P/E (TTM, $1.50 EPS): ~31x at $46; ~52x at $78 (profile cites a "~31-52x" range across sources/price points)
- EV/EBITDA (FY2025, ~$1.16B EBITDA): ~16x at $46; ~17-18x at $78 (profile cites ~11-16x range)
- FCF yield: ~1.0% (FY2025 $191M FCF basis; will be negative FY2026)
- Dividend yield: ~0.8% (small quarterly dividend maintained)
- 52-week range: $16.54 - $79.21 (per checklist); stock within ~1.5% of 52-week high at checklist date
Key FY2025 stats: Revenue $6,708M (+6.2% YoY) | Gross margin 14.0% | Operating margin 7.0% | Net income $374M | Diluted EPS $1.50 | Operating cash flow $1,096M | Capex $905M | FCF $191M | ~248M diluted shares.
Business
What it does. Pure-play manufacturing services: chip designers and fabs send finished silicon wafers to Amkor, which packages them into the form factors that go into electronics and ships finished units back. No proprietary chip products; revenue is recognized per package assembled or per test service on delivery. The company owns all major physical assets (fabs, test equipment) — an asset-heavy model where gross margins run 14-19% depending on cycle and mix, operating margins 7-10%, and FCF is highly sensitive to capex timing.
Why packaging matters. A modern logic chip (CPU, GPU, mobile SoC) is fabbed as a raw silicon die that cannot function on its own — no electrical contacts, no environmental protection, no way to connect to memory, no thermal management. Packaging transforms a bare die into a usable component. As traditional Moore's-Law transistor scaling becomes economically exhausted (TSMC 3nm/2nm mask sets cost $3-5B to design for), the industry's answer is heterogeneous integration — combining multiple specialized dies (logic + memory + I/O) into a single package that performs like a monolithic chip. Advanced packaging is now the primary battlefield for semiconductor performance, and Amkor sits at the center of it.
Segments
- Advanced Products — 82.8% of FY2025 revenue (~$5,556M). Wafer-level fan-out (WLFO/eWLB — Amkor's licensed equivalent of TSMC's InFO), advanced system-in-package (SiP) modules, flip-chip BGA, 2.5D (interposer-based) packaging, and emerging 3D/EMIB work. Within Advanced Products, SiP modules contributed ~$3,080M ($3.1B) of FY2025 net sales (primarily Apple wearables/AirPods). Advanced packages carry ASPs of $3-20+ vs $0.10-2 for mainstream leadframe; SiP modules $5-30+. Advanced Products grew at a ~16% CAGR 2019-2024; mix up from ~65-70% in 2019.
- Mainstream Products — 17.2% of FY2025 revenue (~$1,152M / ~$1.15B). Leadframe packages (QFN, QFP, DIP), substrate-based wirebond, legacy MEMS, older-generation test. Low ASP, high volume, commoditized. Structural decline as a percentage of revenue; Amkor is not investing meaningfully in new mainstream capacity. Hit by automotive/industrial (EV inventory correction) in 2024-2025.
Packaging technology ladder
Wire bonding (legacy, cheap, ~few Gbps) → flip chip (die soldered upside-down via C4 bumps / copper pillars; higher bandwidth) → wafer-level fan-out (reconstituted wafer, RDL built over die for I/O fan-out; Apple A-series uses WLFO) → SiP (multiple components in one package; Apple Watch S-series is the canonical example) → 2.5D (dies side-by-side on a silicon interposer; TSMC CoWoS is the leading version; where AI GPU demand lives) → EMIB (Intel's small silicon bridge chips embedded in substrate only where high-bandwidth die-to-die links are needed; more area-efficient than a full interposer) → 3D stacking / Foveros (logic dies stacked vertically via TSVs and hybrid bonding; most advanced and expensive; Amkor has capability but not yet a major revenue driver).
Customers
- Apple (AAPL): ~30% (29.8% FY2025 disclosed). SiP for wearables/AirPods, advanced packaging for iPhone; anchor for the Arizona campus. $3T+ company, no credit risk. Risk is volume reduction (if Apple shipments decline 15%, Amkor revenue falls ~4-5%), not overnight departure — 18+ months to qualify a new SiP partner. Apple has explored in-house capability; the bear framing is that 30% Apple exposure makes Amkor "an iPhone accessory play in disguise."
- Qualcomm (QCOM): ~11% (11.1% FY2025 disclosed). Fabless; Amkor is its primary packaging partner for Snapdragon (flip-chip BGA, packaged at Korea and other sites). Diversification into PC chips (Snapdragon X) and automotive (Snapdragon Ride) is a tailwind.
- NVIDIA (NVDA): not disclosed (~5-8% estimated). 2.5D AI GPU packaging (H100/H200-class); named anchor for the Arizona campus.
- Intel (INTC): not disclosed (new/emerging). EMIB technology partner + future foundry customer (see Catalysts).
- Samsung (005930.KS): not disclosed. Both a mobile customer and an OSAT competitor (own packaging arm).
- Concentration: top-10 customers = 72% of FY2025 revenue; Apple + Qualcomm together ~41%. Elevated.
Facilities (six countries)
- Korea — K5 / Songdo campus (Incheon): leading-edge advanced packaging hub, SiP, EMIB qualification; new building adding ~20% space by end-2026 for EMIB / HDFO (high-density fan-out).
- Vietnam — Ho Chi Minh City: SiP migration from Korea (frees Korean capacity for higher-margin work), mainstream packaging; came online 2024, reached breakeven Q4 2025.
- Portugal — Porto: advanced packaging, EMIB production (in qualification with Intel).
- Japan — Aizu: legacy IC packaging, automotive/industrial.
- Philippines — Manila area: mature-node packaging and test.
- Arizona — Peoria: under construction; mid-2027 completion; production early 2028; $7B total; Apple and NVIDIA named anchors; 750K+ sq ft cleanroom, up to 3,000 jobs.
Moat & competitive position
Four pillars: (1) customer qualification stickiness — 6-18 months to requalify packaging on a new platform; Apple SiP requires extensive co-development; (2) US-domicile / CHIPS Act policy moat — no other OSAT of Amkor's scale is building US domestic capacity (TSMC Arizona is a foundry, not an OSAT; ASE is Taiwan; JCET/Tongfu are Chinese); (3) advanced packaging IP and 50+ years of process know-how (eWLB licensed, SiP process flows, EMIB qualification); (4) temporary Intel EMIB exclusivity — first OSAT qualified, a 12-24 month head-start competitors would need capital to match. Porter snapshot: supplier power Low (multi-vendor equipment), buyer power High (Apple+Qualcomm ~41%), new-entrant threat Low (billions per campus + qualification cycles), substitute threat Medium (IDM in-house packaging), rivalry Medium-High (ASE dominant; China subsidized). Business-quality verdict: durable, not exceptional — defensible through customer stickiness, policy moat, and scale; incremental gross margin runs ~12% at low utilization to ~19% at peak.
Financials
Historical revenue
| Year | Revenue | YoY |
|---|---|---|
| FY2022 | $7,092M | — (peak; $766M net income) |
| FY2023 | $6,503M | -8.3% |
| FY2024 | $6,318M | -2.8% |
| FY2025 | $6,708M | +6.2% |
| FY2026E | ~$7,200M | ~+7.3% (consensus; possibly conservative) |
FY2025 growth was all organic (no M&A). Computing grew 21% in FY2025 (AI GPU + ARM PC ramp); communications flat-to-up; automotive recovering. Q4 2025 was the strongest quarter (+16% YoY; communications +28% in Q4).
Income statement and margins
| Metric | FY2023 | FY2024 | FY2025 | FY2026E |
|---|---|---|---|---|
| Revenue | $6,503M | $6,318M | $6,708M | ~$7,200M |
| Gross profit | $943M | $933M | $939M | ~$1,020M |
| Gross margin % | 14.5% | 14.8% | 14.0% | ~14.2% |
| EBIT | $470M | $438M | $467M | N/A |
| EBIT margin % | 7.2% | 6.9% | 7.0% | N/A |
| Net income | $360M | $354M | $374M | ~$375M |
| Net margin % | 5.5% | 5.6% | 5.6% | ~5.2% |
| EPS (diluted) | $1.46 | $1.43 | $1.50 | ~$1.50E |
Gross margin declined from 14.8% (FY2024) to 14.0% (FY2025) on Vietnam ramp costs, new equipment installation, and dilution from the equity raise. FY2026 sees further compression — Q1 2026 guided 12.5-13.5% — as Arizona ramp costs hit COGS before revenue materializes. This is a deliberate tradeoff; peak margins on Arizona capacity come 2028-2030.
Second-derivative revenue check (8 quarters)
| Quarter | Revenue | QoQ | YoY | 2nd deriv (YoY Δ) |
|---|---|---|---|---|
| Q1 2024 | $1,366M | — | -8.3% | — |
| Q2 2024 | $1,461M | +7.0% | -4.1% | improving |
| Q3 2024 | $1,862M | +27.4% | +4.2% | improving |
| Q4 2024 | $1,629M | -12.5% | +8.1% | improving |
| Q1 2025 | $1,322M | -18.8% | -3.2% | decelerating (seasonal/mix) |
| Q2 2025 | $1,511M | +14.3% | +3.4% | re-accelerating |
| Q3 2025 | $1,987M | +31.5% | +6.7% | accelerating |
| Q4 2025 | $1,888M | -5.0% | +15.9% | strong |
YoY revenue growth trended from -8.3% (Q1 2024) to +15.9% (Q4 2025). Q1 2026 guidance ($1.65B midpoint) implies +24.8% YoY — the strongest YoY growth since the FY2022 peak; if it materializes, a significant consensus re-rating catalyst. Annualizing the Q1 run rate gives ~$6.6B, but advanced packaging is back-half weighted; full-year $7.2-7.5B is achievable if H2 strength continues.
Incremental margin analysis (YoY, last 8 quarters)
| Q1'25 vs Q1'24 | Q2'25 vs Q2'24 | Q3'25 vs Q3'24 | Q4'25 vs Q4'24 | |
|---|---|---|---|---|
| Δ Revenue (YoY) | -$44M | +$50M | +$125M | +$259M |
| Δ Gross profit (YoY) | -$44.1M | -$30.5M | +$12.0M | +$67.9M |
| Incremental gross margin | 100%+ neg | -61% | +9.6% | +26.2% |
| Δ EBIT (YoY) | -$41.6M | +$10.4M | +$9.6M | +$50.5M |
| Incremental EBIT margin | 94%+ neg | +20.8% | +7.7% | +19.5% |
Q4 2025 is the cleanest signal: on $259M more revenue YoY, Amkor captured $68M more gross profit (26.2% incremental GM) and $50.5M more EBIT (19.5% incremental) — better than the reported 16.7% Q4 gross margin, suggesting the new revenue increment is higher-quality (advanced mix). Sustainable incremental EBIT at scale ~15-20%. Q1 2026 resets downward again as Arizona ramp begins.
Cash flow and balance sheet
| Metric | FY2023 | FY2024 | FY2025 | FY2026E |
|---|---|---|---|---|
| Operating cash flow | $1,270M | $1,089M | $1,096M | ~$1,100M est. |
| Capex | ($749M) | ($744M) | ($905M) | ($2,500-3,000M) |
| Free cash flow | $521M | $345M | $191M | Deeply negative |
| FCF margin % | 8.0% | 5.5% | 2.8% | Negative |
Net cash vs net debt — discrepancy flagged. Sources disagree on the end-2025 balance-sheet position: the prior canonical page and the profile state ~$540M net cash at end-2025; the deep-dive states $474M net debt ("net debt / EBITDA ~0.4x") and the checklist also cites "$474M net debt." These cannot both be true. The most likely reconciliation: Amkor held net cash through FY2024 (~$301M net cash FY2023, ~$402M net cash FY2024 per deep-dive), and the $474M figure is net debt entering the Arizona build after the late-2025 financing draws — but the direction is contradictory across fragments and should be re-verified against the FY2025 10-K. Either way, leverage is low entering the build (~0.4x EBITDA) and rises sharply through 2026-2027.
Capital intensity. FY2025 capex $905M = 13.5% of revenue. FY2026 guided $2.5-3.0B = ~35-42% of $7.2B consensus revenue — extraordinary, justified only if Arizona achieves target utilization by 2028-2029. Funding is in place: $487.5M follow-on equity raise (late 2025/Feb 2026) + $500M note refinancing at a lower coupon + CHIPS Act funds + credit facility + ~$3B liquidity at end-2025. No additional equity raise expected through Phase 1 completion (2027).
ROIC. Strong at the FY2022 peak (~9-11%); compressed to ~4-6% est. in the pre-investment trough — below estimated WACC of ~7-9%, so Amkor is temporarily destroying value in accounting terms while building the foundation. (Profile cites ~8-10% FY2025 est.; deep-dive cites ~4-6% — the lower figure reflects the capex-trough framing.) Recovers post-2028 when Arizona fills.
EBITDA history
| Year | EBITDA | EBITDA Margin |
|---|---|---|
| 2020 | $756M | ~14% |
| 2021 | $960M | ~14% |
| 2022 | $1,331M | ~18.8% |
| 2023 | $1,529M | ~23.5% (flagged anomalous — implies ~$1.06B D&A, high vs revenue; one data provider only; cross-check vs 10-K) |
| 2024 | $1,091M | ~17.3% |
| 2025 | $1,160M | ~17.3% |
Dilution
Share count largely stable: ~248M diluted shares FY2025 (+0.26% YoY before the follow-on). The $487.5M raise added ~10-11M shares (~at ~$45/share) — roughly 4% dilution in one year, a one-time event tied to Arizona funding. No ATM program, no material convertibles or warrants. The Kim family's stake means any raise requires family consent, limiting dilutive opportunism.
Industry landscape
Amkor sits at the packaging-and-test layer — the last high-complexity step after foundry fabrication: Silicon wafers (Shin-Etsu, Sumco) → Foundry (TSMC, Intel, Samsung) → OSAT: Amkor → PCB/module assembly → OEM (Apple, Samsung, Qualcomm) → end consumer. The OSAT industry is moderately consolidated at the top (ASE + Amkor ≈ 60% of the top-10 pool); the bottom tier is fragmented. Barriers to entry are high (cleanroom capital, 12-18 month equipment lead times, qualification cycles, process IP). The industry is highly cyclical (2-3 year downturns, 2-4 year upcycles); the position now is recovery-to-early-expansion — the 2023-2024 correction troughed, FY2025 revenue recovered (+6.2%), Q4 2025 gross margin expanded to 16.7%, computing is in a clear AI upcycle, automotive is a lagged recovery.
The key upstream constraint for Amkor's growth is IC substrate availability (advanced BGA and EMIB-compatible substrates from Ibiden, Shinko, AT&S, Unimicron) — long 6-12 month lead times, capacity additions lag demand. Among equipment suppliers, BESI (BE Semiconductor, Euronext, ~$8B MC) is the highest-leverage advanced packaging play upstream of Amkor, specifically for thermocompression bonding (TCB) used in advanced SiP and EMIB; harder to replace than K&S (KLIC, ~$2B) or ASM Pacific (ASMPT 0522.HK, ~$3B). If Amkor's EMIB and advanced packaging volumes ramp, BESI benefits disproportionately.
See sector page: advanced-packaging
Management
Verdict: B+ (Green-Yellow). Trust this management team with capital. Exceptionally aligned founder-family structure, competent professional management, clean governance record, mild yellow on unproven large-scale capex execution and no buyback track record. No red flags.
Leadership
- Kevin K. Engel — President & CEO (since Jan 1, 2026). BS Chemical Engineering, Auburn. Began as an engineer at National Semiconductor, then Unitive Electronics (Chapel Hill NC advanced-packaging startup); joined Amkor when it acquired Unitive in 2004 and spent 22 consecutive years rising: Corporate VP Flip Chip/Wafer Services → EVP Business Units → EVP & COO (Feb 2025) → CEO. Operational, not promotional. Named COO immediately before the Arizona groundbreaking — the board wanted the operations leader running the company through the construction cycle. No public failures, regulatory actions, or bankruptcies. The fourth CEO in Amkor's history (after founder James Kim, John Kim, Giel Rutten).
- Megan Faust — EVP, CFO & Treasurer (since Feb 2022). Career semiconductor finance executive. Led the company through the FY2022 peak, the 2023-2024 decline, the 2025 recovery, the $487.5M equity raise, and the $500M note refinancing (equity priced $48.75; notes refinanced at a lower coupon). No restatements, no ICFR weaknesses. Limited public profile for a $19B-cap CFO — mildly notable, not unusual.
- Giel Rutten — Former CEO (2019/2020-end 2025), current Board Director; advisory through Mar 31, 2026. Belgian; ex-Philips (1984) and SVP Business Unit Home at NXP; founded/led Ledzworld (LED, ~2012-2014); joined Amkor 2014 as EVP Advanced Products; CEO June 2020 (during COVID, replacing John Kim). Under Rutten: revenue ~$5B (2020) → $7.1B (2022 peak) → $6.7B (2025); advanced mix ~65% → 82.8%; Korea Songdo build-out; Vietnam opened 2024; the $7B Arizona commitment; the Intel EMIB partnership (his final month). CEO transition announced Q3 2025, executed cleanly Jan 1, 2026 — orderly, planned, no governance crisis; succession risk Low.
- Mark Rogers — EVP, General Counsel & Corporate Secretary. 10b5-1 plan adopted Aug 1, 2025 (best practice); exercised $7.40-strike options and sold at $59.43 in Nov 2025 (~$260K gain). Farshad Haghighi — EVP & Chief Sales Officer. Runs all customer relationships; not a named executive officer.
Ownership & alignment
Kim family controls ~52% (older proxy/13D figure carried in the prior canonical page) — more precisely ~49.5% as of Feb 10, 2026 (~122.7M of 247.3M shares outstanding), the post-secondary figure from the mgmt-DD. Institutional ~44-47% (Vanguard, BlackRock, Dimensional, Earnest Partners, American Century, State Street). Non-Kim management/insiders ~1-6%; effective public float is small. Short interest: 8.31M shares (5.87% of float), 2.38 days to cover, below the 7.86% peer average. No activist 13D positions.
Skin in the game (Green). The Kim family's wealth is concentrated almost entirely in AMKR (~$5.8B at $47; ~$10B+ at higher prices) with no diversification into other public equities or ventures — the gold standard of controlling-shareholder alignment. Critically, the family committed ~$47-50M in open-market BUYS at ~$21.85 in 2025 (John T. Kim, Kim David D., Sujoda Investments LP each bought 441,589 shares at $21.85 on Aug 1, 2025 = $9.6M each; Sujoda Management LLC bought 869,565 shares at $21.85 in Feb 2025 = $18.9M) — while simultaneously running the $7B Arizona commitment. That is the highest-conviction possible alignment signal.
Yellow flag — family secondary sale. Feb 12, 2026: Kim family (915 Investments, LP) sold 10,000,000 shares at $48.75 in a secondary offering = $487.5M, more than doubling money vs the $21.85 purchases; a 180-day lock-up was imposed and the family retains ~49.5%. Read as estate/portfolio management and intergenerational transfer, not an exit — but the timing (right after the Q4 2025 beat, just after the company raised equity from public investors, while guiding near-term margin compression) is worth noting. Management option-exercise sells (Engel sold 11,000 shares at $46.21 on Dec 12, 2025 = $508K; 12,500 at $48.75 on Feb 24, 2026 = $609K post-RSU-vest; Rogers, Morse) are normal low-strike exercises, not discretionary divestment.
Governance (Yellow)
11-member board, 9 of 11 independent. Chairman Susan Y. Kim (founding family; daughter of James J. Kim, who moved to Chairman Emeritus Oct 2024). Lead Independent Director Gil C. Tily (Audit, Nom/Gov) balances the family Chairman. John Liu added Dec 2024. Rutten on the board post-retirement (non-independent). Compensation Committee uses independent consultant Compensia; anti-hedging/anti-pledging in place; stock-ownership guidelines disclosed. Annual meeting May 13, 2026. The Kim family's ~49.5% stake is the effective anti-takeover provision (no formal poison pill or staggered board). The governance concern is structural: family control limits practical minority-shareholder accountability — high alignment in favorable periods, low accountability in adverse ones.
Shell / cross-holdings & litigation (Green — clean)
The family structure (James J. Kim → direct holdings + GRATs + 915 Investments LP [John T. Kim sole GP, ~3-4%] + Sujoda Investments LP [~3-4%]) is a conventional multi-generational holding structure that owns only AMKR shares and does not transact with the company. 2026 proxy: "Since January 1, 2025, there have been no related party transactions required to be reported under SEC rules" — the cleanest possible finding. Operating subsidiaries (Korea, Japan, Portugal, Vietnam, Philippines, Taiwan) are wholly owned and fully disclosed in the 10-K. No SEC enforcement; one prior securities class action (re: stock option grants) was dismissed by federal court; patent disputes (v. Tessera 2014, v. Synaptics 2015) are normal IP enforcement by Amkor as plaintiff; a favorable mold-compound litigation verdict. No personal litigation against executives.
Compensation & capital allocation
Rutten FY2025 (final year) total ~$16.9M: base $1.0M, annual bonus $1,498,500 (149.85% of base, tied to operating income of $343.9M), equity awards ~$11.7M, and ~$2.7M "other" (Singapore housing/transport, an NXP-era arrangement — disclosed, but would raise eyebrows at a leaner company). The Compensation Committee cut target bonuses 25% in 2025 (active calibration). Engel FY2026-forward target ~$7M: base $900K, target annual incentive 125% = $1,125,000, $5,000,000 LTI (Feb 2026 grant, RSUs+PSUs), plus a $1,000,000 special RSU vesting Dec 2026/Dec 2027 — ~59% below Rutten (internal promotion, no offshore premium). Annual bonus metric is operating income (better than revenue/EPS — captures cost discipline, resists capital-structure manipulation); PSUs use basic-EPS (one-year) + relative TSR dual metric. SBC ~$8-10M/yr ≈ 0.12-0.15% of revenue — extremely low; negligible dilution.
Capital allocation grade B / Neutral-to-Good: largely organic (no material M&A since J-Devices 2019; Unitive 2004 and J-Devices were complementary, value-additive); the $487.5M equity raise was well-timed (issued expensive stock at a premium multiple to fund Arizona); the $7B Arizona commitment is the right strategic move but untested at this scale; no buyback track record is the main gap — even in the FY2022 peak ($766M net income) the company chose capacity over buybacks, defensible given capital intensity but leaving no data point on whether management understands the equity cost of capital.
Credibility
Guidance tendency: conservative / slight sandbagger. Q4 2025 EPS $0.69 beat ~$0.44 consensus by +57% (an outlier on strong mix); Q2 2025 beat ~8%; Q3 2025 record $1.99B; Q1 2025 met the upper end; Q3 2024 a small -2% EPS miss ($0.49 vs $0.50, automotive weakness). ~80% (4/5) follow-through on tracked statements; appropriate hedging on automotive-recovery timing; no "no current plans" reversals. Credibility rating High.
Catalysts & risks
Catalysts (bull)
Near-term (0-12 months):
- Q1 2026 earnings (April 27, 2026) — guided $1.6-1.7B revenue (~$1.65B midpoint, +24.8% YoY), GM 12.5-13.5%, opex ~$135M, net income $45-70M (EPS $0.18-0.28). Any upside beat is meaningful; this is the single biggest near-term binary event (the checklist was written one day before).
- Intel 18A external tape-out wins — if Intel announces external customers (Qualcomm, Broadcom, NVIDIA) using 18A, the EMIB revenue thesis materializes.
- Arizona construction milestones — equipment delivery, cleanroom installation commentary each earnings call.
- Automotive inventory normalization — would re-rate the 15-20% automotive segment.
- CHIPS Act final agreement — the ~$407M grant is preliminary/non-binding; final contracting pending; any delay is a headline risk.
Medium-term (1-3 years):
- Arizona Phase 1 production (early 2028) — first US-soil advanced packaging at scale; the defining strategic milestone.
- Intel EMIB revenue ramp (2026-2027) — Korea production by late 2026; EMIB-M first, EMIB-T (with TSVs) 2026-2027; volume depends on Intel foundry wins. Modest revenue 2026, material 2027+; industry estimates hundreds of millions at maturity.
- TSMC CoWoS overflow to OSAT (2026-2027) — as TSMC opens CoW orders to partners, Amkor is best-positioned to absorb overflow.
- Computing end-market growth — if AI GPU packaging demand grows 20%+/yr, computing could approach 40% of revenue by 2027.
Why now. Advanced packaging became the single biggest bottleneck in the AI chip supply chain in 2025-2026 — not wafer fab, not HBM. CoWoS demand grew from 370K wafers (2024) to a projected 670K (2025) and 1M+ (2026); NVIDIA alone ~595K wafers projected in 2026 (60% of global), and it is still oversubscribed. Capacity additions take 18-24 months minimum. Consensus is fixated on near-term margin compression and elevated capex; the underappreciated setup is that Amkor in 2028 will be the only US-soil advanced packaging campus at scale exactly when policy and customer supply-chain requirements make US-domiciled packaging essential — a strategic infrastructure moat, not just a growth capex project.
Risks (bear)
| Risk | Likelihood | Mitigant / note |
|---|---|---|
| Apple concentration (~30%) | Medium | Long qualification cycles; Arizona aligns Apple's US supply chain. Structural — Apple stays top customer for years. |
| Arizona capex execution ($7B, 2-phase, 3+ yr) | Medium | Phase 1 only ($3.5B); CHIPS funding de-risks; Apple/NVIDIA demand anchors; prior Korea/Vietnam builds. Closes when Phase 1 ramps 2028-2029. |
| FCF deeply negative 2026-2027 | High (by design) | $487.5M raise + $500M refi + ~$3B liquidity + CHIPS grants; all guided. Closes when Phase 1 ramps. |
| Intel EMIB thesis fails | Medium | Revenue ~zero today — risk is to upside not downside; but the thesis impact is high if Intel 18A wins no external customers. |
| China competition (JCET +19.3% in 2024, Tongfu) | High (ongoing) | Subsidized pricing compresses mainstream margins; Chinese OSATs 2-3 years behind on high-end (EMIB, leading SiP). Arizona = China-proof supply chain. Structural — China improves over time. |
| Automotive softness | Medium | ADAS/EV inventory correction; 15-20% of revenue exposed; 2026-2027 recovery expected. |
| Kim family control (~49.5-52%) | n/a | Limits minority influence; governance concentration. |
| Macro recession / AI capex pause | Low-Medium | AI capex is the most durable secular trend; Apple provides a baseline; cyclical not structural if it occurs. |
| TSMC vertical integration | Low near-term | TSMC is opening CoW orders to OSATs, not closing them. |
| Hybrid bonding transition | Medium-term | Die-to-wafer direct bonding (no bumps) adopted in HBM4 2026-2027; would require new equipment/process investment. |
Bear case / thesis-invalidation triggers: Arizona Phase 1 delayed to 2029; Intel 18A attracts no external customers (EMIB volume thesis evaporates); Apple announces partial SiP insourcing for Watch/AirPods (-20%+ Amkor SiP); broad AI capex pullback in 2027; TSMC stops directing overflow to OSAT partners; gross margin fails to recover above 14% even as Arizona ramps (pricing-power impairment). In a combined bear scenario (Arizona delayed 12 months, Intel EMIB minimal, Apple -20% volume): FY2027 revenue ~$6.5B, EBITDA ~$1.0-1.2B, trough 8x EV/EBITDA → EV ~$8-10B → market cap ~$6-9B → stock ~$24-28/share (~40-50% downside from $46; ~64-68% from $78).
Valuation / DCF
Verdict: STRETCHED at $78; reasonable at $46. The long-term thesis is intact across both price points; what changed during the research swarm was the entry, not the thesis. At $78 the stock had moved 70% and traded 48% above analyst consensus ($52.88), 80% above its 50-day MA (~$43.41), 115% above its 200-day MA (~$36.20), with RSI 70-74 (overbought) and within ~1.5% of its 52-week high ($79.21) — a pure momentum breakout into a binary Q1 2026 earnings event. This is a valuation/timing problem, not a thesis problem.
Multiples (two price points)
| Metric | At ~$46 (deep-dive) | At ~$78 (checklist) |
|---|---|---|
| Market cap | ~$11.4B (checklist) / ~$19.4B (deep-dive, stale) | ~$19.4B |
| Enterprise value | ~$18.9B | ~$19.9B |
| P/E (TTM, $1.50 EPS) | ~31x | ~52x |
| P/E (FY2026E, $1.77 EPS) | ~26x | ~44x |
| P/E (FY2027E, $2.32 EPS) | ~20x | ~34x |
| EV/EBITDA (FY2025, $1.16B) | ~16x | ~17-18x |
| FCF yield (FY2025, $191M) | ~1.7% | ~1.0% |
Note the share-count tension: the deep-dive cites ~$19.4B market cap at ~$46 while the checklist cites ~$11.4B at $46 and ~$19.4B at $78 (~248M shares). The checklist figures are internally consistent; the deep-dive's "$19.4B at $46" appears to be the stale/erroneous figure carried forward.
Peer comparison
| Company | EV/EBITDA | P/E | FCF yield | Notes |
|---|---|---|---|---|
| Amkor (AMKR) | ~16x ($46) / ~17-18x ($78) | ~31x / ~52x | ~1% | Capex trough; elevated |
| ASE Technology (ASX) | ~8-10x | ~12-15x | ~5-7% | More mature; lower growth |
| JCET | n/a | — | — | Chinese; government-backed |
Amkor trades at a 50-100% premium to ASE on EV/EBITDA, entirely for US-domicile policy moat and Arizona optionality. Amkor's own historical range is ~6-12x EV/EBITDA through cycles, so even ~16x is a significant premium to its own history.
Scenario valuation
- Bull case: Arizona ramps to $1B+ revenue by 2028, Intel EMIB contributes $300-500M by 2028, computing continues 20%+. FY2028 revenue ~$9-10B, EBITDA ~$1.8-2.0B at 18-20% margin. At 12x EV/EBITDA, EV ~$22-24B → market cap ~$20-22B — roughly flat to +20% from $46. A modest bull case, which explains why buy-side conviction is not overwhelming.
- Bear case: Arizona delayed 12 months, Intel EMIB <$200M by 2027, sluggish auto recovery. FY2027 EBITDA ~$1.0-1.2B at 8x trough multiple → EV ~$8-10B → market cap ~$6-9B → stock ~$24-28 (~50% downside from $46).
- Implied-price (DCF-sense) math at $78: at a normalized 20x OSAT P/E, $78 requires EPS ~$3.90 (≈ $10-11B revenue at 3.5-4% net margin, achievable ~2030 if Arizona fills + Intel EMIB contributes); at a premium 25x (justified for a reshoring beneficiary), $78 requires EPS ~$3.12 (≈ $8.5-9B revenue, achievable 2028-2029). Amkor's earnings are structurally capped by the asset-heavy model (14-18% gross, 7-10% EBIT) — this is not a software business that expands margins to 30%+; the multiple is driven by narrative (Arizona, Intel EMIB, AI packaging), not current fundamentals.
The value unlock requires margin expansion above historical ranges (20%+ EBITDA margin) as Arizona fills, plus Intel EMIB creating a new revenue stream not yet in models — the two sources of upside beyond consensus.
Analyst sentiment
~8-10 analysts; Buy-leaning (~38% Strong Buy, 13% Buy, 50% Hold, 0% Sell). Price targets $39-53 range; central consensus ~$43-47; consensus average $52.88; Goldman Sachs raised target $38→$43 (Neutral); Melius Research upgrade with a $60 target (surpassed by the stock at $78). FY2026 consensus: ~$7.2B revenue, EPS ~$1.50. At $78 the stock had run above all analyst targets — a momentum event, not a consensus-supported buy.
Decision log
2026-04-26 — Profile / deep-dive (research entry ~$46-47): Bull on the advanced packaging supercycle; Amkor is the best US-domiciled vehicle. Conviction Medium — structural position clear, near-term execution risk real. No target price set in the deep-dive (research, not recommendation). Bear case target ~$24-28 (~40-50% downside) if Arizona delayed 12+ months and Intel EMIB fails. Key watch items: Q1 2026 earnings beat/miss; Intel 18A external tape-out announcements; Arizona construction milestones; gross margin recovery above 14% by Q4 2026.
2026-04-26 — Management DD verdict: B+ (Green-Yellow). Trust this management team with capital. Green on skin-in-the-game (Kim family ~$50M open-market buys at $21.85 while running the $7B Arizona commitment; net family ~49.5%, wealth all-in on AMKR), holdings concentration, shell/cross-holdings (zero related-party transactions in 2025 proxy), compensation alignment (SBC 0.12% of revenue; operating-income + EPS + relative-TSR metrics), credibility (~80% follow-through, conservative guidance), and litigation (no SEC enforcement). Yellow on capital allocation (no buyback track record; $7B capex untested at scale) and governance (Kim family control limits practical accountability). Red flags: none. Yellow watch item: Kim family 10M-share secondary at $48.75 (Feb 2026; 180-day lock-up; family retains 49.5%).
2026-04-26 — Pre-buy checklist (entry under consideration ~$78, one day before Q1 earnings): WATCH — do not buy before Q1 2026 earnings (April 27, 2026). FundamentEdge gates: PASS on all 5 (revenue-growth path credible; strongly positive second derivative, +25% YoY Q1 guided; thesis is structural not valuation-based; quality adequate-not-exceptional; revisions upward) — with caveats on Gate 3 (52x TTM P/E) and Gate 5 (RED FLAG: stock 48% above analyst consensus $52.88). Valuation STRETCHED. FOMO flagged as the primary behavioral risk — stock ran ~70% from research entry (~$46) to ~$78 during the analysis. Technicals: overbought (RSI 70-74), 80% above 50-day MA, within ~1.5% of 52-week ATH, binary Q1 earnings next day — WAIT, do not buy at $78. Management alignment confirmed Green. Target entry on post-earnings price discovery: $55-70 (beat + strong guide vs in-line/miss), $45-50 only if the Arizona timeline or margin trajectory deteriorates beyond guidance. Max position 2-3% of portfolio; scale to 5% only after Arizona Phase 1 equipment-installation milestone (2026). Maximum acceptable loss / stop-loss: 25% from entry. Bear case from $78 entry: -64% to -68%.
Re-evaluation triggers (from deep-dive + checklist): Add — Q1 2026 earnings beat + guidance raise; Intel announces external 18A customer. Hold — in-line earnings; Arizona on schedule. Trim — gross margin fails to recover above 14% by Q4 2026; Arizona delay >6 months. Exit — Apple volume reduction >20%; Arizona delay >12 months; Intel EMIB abandoned.
Consolidation note (2026-05-30): This page is a thesis-first union of the April 26 profile, deep-dive, management DD, and pre-buy checklist, plus the prior canonical page. Prices and stances are as-of the April 2026 research dates and have NOT been refreshed to live — verify current price/cap/PE before acting. Open data discrepancies preserved inline: end-2025 net cash (~$540M) vs net debt ($474M); market cap at $46 (~$11.4B vs ~$19.4B); Kim family stake ~49.5% (Feb 2026) vs ~52% (older); FY2023 EBITDA $1,529M flagged anomalous.
Sources
Fragments folded in (consolidated 2026-05-30): amkr-profile.md (profile, 2026-04-26), amkr-deep-dive.md (deep-dive, 2026-04-26, Intel supply chain swarm), amkr-mgmt-dd.md (management DD, 2026-04-26), amkr-buy-checklist.md (pre-buy checklist, 2026-04-26), and the prior canonical amkr.md. A *-filings.md placeholder stub in the folder was empty and not merged.
Briefings: 2026-04-26 · Amkor Technology (AMKR) · vault
External sources cited across fragments:
- Amkor Technology IR: ir.amkor.com — press releases, annual reports, 10-K/10-Q, DEF 14A; July 2025 Investor Presentation
- Q4 2025 / FY2025 results press release; Q3 2025 earnings / CEO succession announcement; Arizona groundbreaking / $7B investment release; Kim family secondary offering (10M shares at $48.75, Feb 12, 2026)
- Intel EMIB partnership blog (amkor.com); IFTLE 651: Intel and Amkor join forces for EMIB (3dincites.com)
- TrendForce: OSAT Rankings 2024; TrendForce: TSMC CoWoS bookings / OSAT expansion
- TradingKey: Q1 2026 earnings preview; Futurum Group: Q4 2025 advanced packaging analysis; Benzinga: bear case / valuation concern
- StockAnalysis.com (quarterly financials, balance sheet); MacroTrends; Investing.com (insider trades, earnings transcripts); Goldman Sachs research note; SemiAnalysis: Advanced Packaging Part 3 (paywall)
- 2026 DEF 14A proxy (via StockTitan); Form 4s (Engel, Rogers); John T. Kim $9.6M and Sujoda Management $18.9M open-market purchases (Investing.com); Schedule 13D/A (Oct 2024, capedge); Amkor leadership pages (Engel, Rutten); Amkor IR: dismissal of securities lawsuit; Giel Rutten compensation (fintool)
- Yole Group, Acumen Research (advanced packaging TAM ~$44B 2025 → $79-117B by 2030-2035, ~9-10% CAGR)
Research date for all merged fragments: 2026-04-26. Forward estimates are analyst consensus. Prices are research-date snapshots, not live.
Topics
- ai-infrastructure
- optical-components
- supply-chain-security
- green-finance
- _MOC-Stocks
Consolidation queue (merged 2026-05-30)
These fragment files were folded into this canonical page on 2026-05-30 and remain live pending Pink's archive confirmation.
- [ ]
amkr-deep-dive.md - [ ]
amkr-profile.md - [ ]
amkr-buy-checklist.md - [ ]
amkr-mgmt-dd.md - [ ]
amkr.md
Source updates (auto-maintained)
Drop/z Misc (Apr 2, 25) - Hyundai Motor Securities – Field Trip Report on Japanese and...
Hyundai Motor Securities' April 2025 field trip confirms TSMC's CoWoS capacity reservations increased in March (NVIDIA +10% to 437K, Broadcom +10% to 75K), and that HBM demand is expanding aggressively — but Amkor and OSAT packaging are not directly discussed; the report focuses on memory, HBM testers, and foundry.
Relevant to your thesis: Corroborates the AI packaging demand backdrop underpinning Arizona utilization assumptions, but contains no Amkor-specific signal.
Source: dropfile://z Misc/Hyundai Motor Securities – Field Trip Report on Japanese and Taiwanese Companies.pdf